Donald Olds - 31 Aug 2023 Form 4 Insider Report for Acasti Pharma Inc. (GRCE)

Role
Director
Signature
/s/ Prashant Kohli, as attorney-in-fact
Issuer symbol
GRCE
Transactions as of
31 Aug 2023
Net transactions value
+$781
Form type
4
Filing time
05 Sep 2023, 15:54:48 UTC
Previous filing
18 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACST Common Shares Purchase $781 +381 $2.05 381 31 Aug 2023 Direct
holding ACST Common Shares 792 31 Aug 2023 Ofra Aslan (Spouse) F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These indirect holdings have been adjusted to give effect to the Company's 1-for-8 reverse stock split, effective August 31, 2021, and the Company's 1-for-6 reverse stock split, effective July 10, 2023.
F2 792 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.